Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Proposed Sales

Track CHRS — free
$0.77 +0.02 (+2.82%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Market Cap
$118.97M
Shares
154.50M
Volume · Nov 6 1.08M Avg daily vol (3M) 1.45M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2023-11-22 Lanfear Dennis M 223,100
Showing 1–1 of 1 filings
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 72 filings 49 filers Visit website Investor relations